Built and executed scientific strategic plans on the inaugural thought leader liaison team at Clovis Oncology supporting prostate and ovarian cancer approved indications. Responsible for identifying and developing current and future Key Opinion Leaders.Primary liaison for internal cross functional groups including medical affairs, market access, commercial operations and executive leadership.Optimized field strategy, developed tactical plan, orchestrated advisory boards and scientific round tables and executed congress and conference strategy in collaboration with commercial operations, national sales director, market access and medical affairs.

Director of business development and primary scientific community liaison. Deeply involved in product development, client recruitment and retention and investor presentations. Primarily responsible for recruitment, retention and communication to clients, researchers, research organizations and funding agency clients. Invited panelist at national meetings on life science innovation. Created and launched consulting practice providing customized, researched, commissioned, confidential overview reports for life science business development, legal and R&D community.

Strategic business planning, regulatory strategy, clinical trials and scientific advising for biopharma companies, especially those with Colorado roots.

BioScience VC, M&A and IPO Data. Organized and reported life science private venture financings, providing timely coverage and comprehensive analysis of global bioscience venture capital investment activity.

Clinical research experience encompassing over 20 unique studies acquired as lead clinical research coordinator in a CNS/neurology/pain/psych research center. Assisted in design and execution of clinical investigator-initiated studies, demonstrating understanding of clinical trials demands and processes. Served as primary liaison between pharmaceutical companies, clinical research organizations (CROs), institutional review boards, patients and clinic staff to ensure timely, accurate, highly organized completion of clinical studies.